Status:
COMPLETED
Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea
Lead Sponsor:
Michael E. DeBakey VA Medical Center
Collaborating Sponsors:
Baylor College of Medicine
Conditions:
Enterocolitis
Pseudomembranous Colitis
Eligibility:
All Genders
18+ years
Brief Summary
The investigators propose to study intensively the bacteriology of feces in C. difficile associated diarrheal disease, using a variety of conventional and very up-to-date techniques.
Detailed Description
Clostridium difficile associated colitis is an increasing problem in hospitals throughout the developed world; the number of cases has increased, and the failure to respond to conventional therapy has...
Eligibility Criteria
Inclusion
- Patients with antibiotic-associated diarrhea with a positive assay for C. difficile toxin
- Patients with antibiotic-associated diarrhea with 3 negative assays for C. difficile toxin
- Patients with antibiotic-associated diarrhea that has failed to respond to conventional therapy
- Hospitalized patients who have received \>2 antibiotics and who have no symptoms of diarrhea or abdominal discomfort
Exclusion
- none
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00304876
Start Date
October 1 2005
End Date
January 1 2007
Last Update
September 10 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Medical Research Institute
Baltimore, Maryland, United States, 21205
2
Michael E. DeBakey Veterans Affairs Medical Center
Houston, Texas, United States, 77030